InvestorsHub Logo
Followers 829
Posts 119610
Boards Moderated 14
Alias Born 09/05/2002

Re: willyw post# 641

Sunday, 10/12/2014 2:28:45 PM

Sunday, October 12, 2014 2:28:45 PM

Post# of 2958

Is it possible that Abbvie 3D may be approved for some indications for only 12 weeks where Gilead is labeled for 24 weeks (in cirrhotic past failures)? I'm not asking if it is a shoo in, but possible?

Based on the TURQUOISE-2 data (#msg-96696670), it’s possible. This will be one of the FDA’s most consequential decisions on the ABBV/ENTA NDA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News